Fighting cancer with re-engineered immune cells: early trial seeks to tame tough lymphomas
Disease control
Recruiting now
This is an early-stage study testing the safety of a personalized cell therapy for adults with specific types of non-Hodgkin lymphoma that have come back or not responded to standard treatments. Doctors will modify a patient's own immune cells to better target and fight their can…
Phase: PHASE1 • Sponsor: C. Babis Andreadis • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC